U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564089) titled 'Thymus Dosimetric and Morphologic Predictors of Radiation-Induced Lymphopenia in Stage III NSCLC' on April 26.
Brief Summary: This study is being done to find out whether features of the thymus gland can predict a common side effect of radiation therapy for lung cancer called radiation-induced lymphopenia.
We will include adults with stage III non-small cell lung cancer (NSCLC) who are scheduled to receive curative radiation therapy to the chest, with or without chemotherapy.
Before, during, and after radiation therapy, we will measure:
The dose of radiation that reaches the thymus gland (based on each patient's treatment plan)
Th...